XML 43 R25.htm IDEA: XBRL DOCUMENT
v3.25.1

STOCK-BASED COMPENSATION | 12 Months Ended
--- | ---
Dec. 31, 2024
Compensation Related Costs [Abstract] |
STOCK-BASED COMPENSATION | NOTE 15 – STOCK-BASED COMPENSATION Pursuant to the Company’s 2019 Omnibus Equity Incentive Plan adopted and approved in 2019 (“2019 Plan”), awards under the 2019 Plan is limited in the aggregate to 2,068,398 shares of our common stock, inclusive of the awards that were previously issued and outstanding under the Company’s 2007 Equity Incentive Plan, as amended (the “2007 Plan”). Upon adoption and approval of the 2019 Plan, the 2007 Plan was frozen, no new awards will be granted under the 2007 Plan, and outstanding awards under the 2007 Plan will continue to be governed by the terms and condition of the 2007 Plan and applicable award agreement. As of December 31, 2024, the number of shares of the Company’s common stock available for grant of stock options and issuance under the 2019 Plan is 561,801 shares. The fair value of each option award is estimated on the date of grant using the Black-Scholes option-pricing model. The risk free rate is based on the yield-to-maturity in continuous compounding of the US Government Bonds with the time-to-maturity similar to the expected tenor of the option granted, volatility is based on the annualized historical stock price volatility of the Company, and the expected life is based on the historical option exercise pattern. For the year ended December 31, 2024 and 2023, total compensation costs for options issued recorded in the consolidated statement of comprehensive income (loss) were $0 and $0. There were no related tax benefits as a full valuation allowance was recorded in the years ended December 31, 2024 and 2023. NOTE 15 – STOCK-BASED COMPENSATION – Continued The following table summarizes all Company stock option transactions between January 1, 2024 and December 31, 2024. Stock-Based Compensation - Schedule of Stock Option Activity
|  |  | Number of Option and Warrants Outstanding and exercisable |  |  |  | Weighted- Average Exercise price of Option and Warrants |  |  |  | Range of Exercise Price per Common Share |
Balance, January 1, 2024 |  |  | — |  |  | $ | — |  |  | $ | — |
Exercised |  |  | — |  |  | $ | — |  |  | $ | — |
Expired |  |  | — |  |  |  | — |  |  |  | — |
Balance, December 31, 2024 |  |  | — |  |  |  | — |  |  |  | — |
Stock and Warrants Options Exercisable and Outstanding |
|  |  | Outstanding at December 31, 2024 |  |  |  | Range of Exercise Prices |  |  |  | Weighted Average Remaining Contractual Life (Years) |
Exercisable and outstanding |  |  | — |  |  |  | — |  |  |  | — |
All options exercisable and outstanding at December 31, 2024 are fully vested. As of December 31, 2024, there was no unrecognized compensation cost related to outstanding stock options, The aggregate intrinsic value of options outstanding and exercisable as of December 31, 2024 and 2023 was $0 and $0.

X
- References No definition available. + Details
Name: | us-gaap_CompensationRelatedCostsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for compensation costs, including compensated absences accruals, compensated absences liability, deferred compensation arrangements and income statement compensation items. Deferred compensation arrangements may include a description of an arrangement with an individual employee, which is generally an employment contract between the entity and a selected officer or key employee containing a promise by the employer to pay certain amounts at designated future dates, usually including a period after retirement, upon compliance with stipulated requirements. This type of arrangement is distinguished from broader based employee benefit plans as it is usually tailored to the employee. Disclosure also typically includes the amount of related compensation expense recognized during the reporting period, the number of shares (units) issued during the period under such arrangements, and the carrying amount as of the balance sheet date of the related liability. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 710 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/710/tableOfContent Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 710 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482969/710-10-50-1 + Details
Name: | us-gaap_CompensationRelatedCostsGeneralTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration